These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14118921)

  • 21. A NEW APPROACH TO BACTERIAL VACCINES.
    GREENBERG L
    Can Med Assoc J; 1963 Aug; 89(9):396-402. PubMed ID: 14042791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK; Edwards KM
    Pediatr Infect Dis J; 2006 Apr; 25(4):374-5. PubMed ID: 16567996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned.
    Schneerson R; Robbins JB; Taranger J; Lagergård T; Trollfors B
    Lancet; 1996 Nov; 348(9037):1289-92. PubMed ID: 8909384
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune responses and reactions to diphtheria and tetanus toxoids, with pertussis vaccine, aluminum phosphate precipitated.
    McCOMB JA; TRAFTON MZ
    N Engl J Med; 1950 Sep; 243(12):442-4. PubMed ID: 14775857
    [No Abstract]   [Full Text] [Related]  

  • 25. DEVELOPMENT OF PERTUSSIS VACCINE PRODUCTION AND CONTROL IN THE NATIONAL INSTITUTE OF PUBLIC HEALTH IN THE NETHERLANDS DURING THE YEARS 1950--1962.
    COHEN HH
    Antonie Van Leeuwenhoek; 1963; 29():183-201. PubMed ID: 14047151
    [No Abstract]   [Full Text] [Related]  

  • 26. From the Centers for Disease Control and Prevention. Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine.
    JAMA; 2001 Apr; 285(13):1698. PubMed ID: 11302151
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of the immune response to whooping cough and tetanus vaccines by malaria infection, and the effect of pertussis adjuvant.
    Tarzaali A; Viens P; Quevillon M
    Am J Trop Med Hyg; 1977 May; 26(3):520-4. PubMed ID: 869103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PREPARATION OF THE REFERENCE DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AND STARDARDIZATION OF ITS DIPHTHERIA AND TETANUS COMPONENTS. I. THE DIPHTHERIA COMPONENT].
    GALAZKA A
    Med Dosw Mikrobiol; 1964; 16():295-308. PubMed ID: 14313908
    [No Abstract]   [Full Text] [Related]  

  • 29. [HEMOLYTIC-UREMIC SYNDROMES FOLLOWING TRIPLE VACCINATION (DIPHTHERIA-PERTUSSIS-TETANUS)].
    GUERRA AU; LORENZOYDEIBARRETA J; TEMESIO N
    Arch Pediatr Urug; 1965 Jan; 36():26-38. PubMed ID: 14294753
    [No Abstract]   [Full Text] [Related]  

  • 30. FACTORS INVOLVED IN THE STABILITY OF PERTUSSIS COMPONENT IN QUADRUPLE DPT-POLIO VACCINE.
    PONTECORVO M
    Riv Ist Sieroter Ital; 1964; 39():464-9. PubMed ID: 14259054
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxoid vaccine for pertussis.
    von König CH; Schmitt HJ
    Lancet; 1997 Jan; 349(9045):136; author reply 137-8. PubMed ID: 8996450
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(10):189-90. PubMed ID: 11280456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoid vaccine for pertussis.
    Preston NW; Matthews RC
    Lancet; 1997 Jan; 349(9045):137; author reply 137-8. PubMed ID: 8996452
    [No Abstract]   [Full Text] [Related]  

  • 34. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
    Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
    Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reactions to adsorbed pertussis-diphtheria-tetanus vaccine].
    Zakharova MS; Vares AM; Vorob'eva AI; Ustinova VG
    Pediatriia; 1971 Jan; 50(1):65-8. PubMed ID: 5573533
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical characteristics and immunological indices in children immunized with DPT vaccine on a disrupted schedule].
    Aleksina SG; Veĭsfeĭler OIu; Podshivalova VA; Kovalskaga SYa ; Braginskaia VP
    Vopr Okhr Materin Det; 1974 Sep; 19(9):47-50. PubMed ID: 4422421
    [No Abstract]   [Full Text] [Related]  

  • 37. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization against diphtheria, pertussis and tetanus.
    Rubio T
    J Okla State Med Assoc; 1969 Mar; 62(3):100-2. PubMed ID: 5774602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.